AERI - Aerie Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
30/12/2015
Cash flows from operating activities
Net income
-195,975
-232,569
-145,105
-99,059
-74,363
Depreciation & amortisation
4,322
2,442
1,410
970
252
Deferred income taxes
-
-
-
-
-
Stock-based compensation
43,634
38,728
26,078
16,794
12,945
Change in working capital
-13,634
13,388
-1,314
627
4,545
Accounts receivable
-31,317
-2,715
-
-
-
Inventory
-8,470
-9,689
-
-
-
Accounts payable
34,235
26,583
925
2,479
5,385
Other working capital
-164,640
-183,889
-109,183
-84,917
-59,026
Other non-cash items
7,034
25,636
25,108
303
305
Net cash provided by operating activities
-154,820
-152,576
-93,213
-79,840
-55,746
Cash flows from investing activities
Investments in property, plant and equipment
-9,820
-31,313
-15,970
-5,077
-3,280
Acquisitions, net
-
0
-10,500
-
-
Purchases of investments
-97,268
-56,195
-104,490
-35,169
-46,872
Sales/maturities of investments
1,000
108,297
88,153
58,346
59,534
Other investing activities
-
-
-
0
0
Net cash used for investing activities
-106,088
20,789
-42,807
18,100
9,382
Cash flows from financing activities
Debt repayment
-
-
-
-
-
Common stock issued
3,630
139,602
135,644
168,479
50,451
Common stock repurchased
-
-
-
-
-
Dividends paid
-
-
-
-
-
Other financing activities
-34,168
-2,566
-
-1,249
0
Net cash used provided by (used for) financing activities
274,656
137,036
135,644
168,625
51,838
Net change in cash
13,748
5,249
-376
106,885
5,474
Cash at beginning of period
234,954
197,569
197,945
91,060
85,586
Cash at end of period
248,702
202,818
197,569
197,945
91,060
Free cash flow
Operating cash flow
-154,820
-152,576
-93,213
-79,840
-55,746
Capital expenditure
-9,820
-31,313
-15,970
-5,077
-3,280
Free cash flow
-164,640
-183,889
-109,183
-84,917
-59,026
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more